ARTICLE | Clinical News
Cytogen data
March 29, 1993 8:00 AM UTC
A CYTO spokesperson said that while the results demonstrated the superiority of the indium-labeled, intact MAb over the technetium-labeled fragments, CYTO would continue to work with both. The company...